Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 75 | 0 | 12 | 0 | €830.00 | €831.01 | 0.121% |
Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €418.85 | €450.36 | 7.524% |
Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,024.0 | €1,087.6 | 6.207% |
Johnson & Johnson | 41 | 1 | 5 | 0 | €147.18 | €193.18 | 31.253% |
AbbVie Inc. | 34 | 0 | 1 | 0 | €172.98 | €180.90 | 4.581% |
Merck & Co. Inc. | 32 | 1 | 2 | 0 | €104.80 | €126.38 | 20.592% |
BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €63.22 | €100.74 | 59.345% |
Amgen Inc. | 28 | 0 | 1 | 0 | €302.20 | €304.82 | 0.866% |
Pfizer Inc. | 30 | 4 | 5 | 0 | €26.21 | €40.68 | 55.255% |
Novo Nordisk A/S ADR | 26 | 1 | 4 | 0 | €114.00 | €144.83 | 27.046% |
Zoetis Inc. A | 23 | 1 | 2 | 0 | €172.34 | €196.17 | 13.825% |
Abbott Laboratories | 21 | 0 | 3 | 0 | €102.26 | €116.71 | 14.134% |
Teva Pharmaceutical Industries Ltd ADR | 20 | 0 | 2 | 0 | €15.60 | €19.37 | 24.169% |
Exact Sciences | 20 | 0 | 3 | 0 | €61.70 | €76.55 | 24.062% |
Incyte Corp. | 14 | 2 | 1 | 0 | €59.50 | €78.05 | 31.171% |
Gilead Sciences Inc | 11 | 0 | 1 | 0 | €74.76 | €85.74 | 14.683% |
Sanofi S.A. ADR | 9 | 0 | 3 | 0 | €52.50 | €55.25 | 5.246% |
Elanco Animal Health Inc. | 9 | 2 | 1 | 0 | €13.00 | €16.68 | 28.304% |
Bayer AG | 17 | 10 | 5 | 9 | €28.59 | €45.00 | 57.398% |
Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
GSK plc ADR | 5 | 0 | 0 | 0 | €37.00 | €49.33 | 33.316% |
Merck KGaA | 5 | 1 | 1 | 0 | €157.90 | €172.00 | 8.930% |
Sanofi S.A. | 4 | 0 | 0 | 0 | €102.84 | €109.00 | 5.990% |
Novartis AG ADR | 3 | 0 | 0 | 0 | €104.00 | €112.40 | 8.074% |
AstraZeneca plc | 2 | 0 | 0 | 0 | €140.85 | €165.00 | 17.146% |